Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;17(8):1297-1306.
doi: 10.1002/alz.12296. Epub 2021 Feb 9.

COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US

QuanQiu Wang  1 , Pamela B Davis  2 , Mark E Gurney  3 , Rong Xu  1
Affiliations

COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US

QuanQiu Wang et al. Alzheimers Dement. 2021 Aug.

Abstract

Introduction: At present, there is limited data on the risks, disparity, and outcomes for COVID-19 in patients with dementia in the United States.

Methods: This is a retrospective case-control analysis of patient electronic health records (EHRs) of 61.9 million adult and senior patients (age ≥ 18 years) in the United States up to August 21, 2020.

Results: Patients with dementia were at increased risk for COVID-19 compared to patients without dementia (adjusted odds ratio [AOR]: 2.00 [95% confidence interval (CI), 1.94-2.06], P < .001), with the strongest effect for vascular dementia (AOR: 3.17 [95% CI, 2.97-3.37], P < .001), followed by presenile dementia (AOR: 2.62 [95% CI, 2.28-3.00], P < .001), Alzheimer's disease (AOR: 1.86 [95% CI, 1.77-1.96], P < .001), senile dementia (AOR: 1.99 [95% CI, 1.86-2.13], P < .001) and post-traumatic dementia (AOR: 1.67 [95% CI, 1.51-1.86] P < .001). Blacks with dementia had higher risk of COVID-19 than Whites (AOR: 2.86 [95% CI, 2.67-3.06], P < .001). The 6-month mortality and hospitalization risks in patients with dementia and COVID-19 were 20.99% and 59.26%, respectively.

Discussion: These findings highlight the need to protect patients with dementia as part of the strategy to control the COVID-19 pandemic.

Keywords: Alzheimer's disease; COVID-19; dementia; patient electronic health records.

PubMed Disclaimer

Conflict of interest statement

QuanQiu Wang, Pamela B. Davis, Mark E. Gurney and Rong Xu have no financial interests to disclose.

Figures

FIGURE 1
FIGURE 1
Odds of COVID‐19 in patients with dementia compared to patients without dementia, after adjusting for age, sex, race, and COVID‐19 risk factors including asthma, cardiovascular diseases, cancer, type 2 diabetes, obesity, chronic kidney diseases, chronic obstructive pulmonary disease, substance use disorders, transplant procedures (bone marrow, solid organ), and nursing home stay status. AOR, adjusted odds ratio; CI, confidence interval
FIGURE 2
FIGURE 2
Odds of COVID‐19 in patients with dementia compared to patients without dementia, after adjusting for demographics (age, sex, race). AOR, adjusted odds ratio; CI, confidence interval
FIGURE 3
FIGURE 3
Effects of demographics on odds of COVID‐19 among patients with dementia, after adjusting for age, sex, race, and COVID‐19 risk factors including asthma, cardiovascular diseases, cancer, type 2 diabetes, obesity, chronic kidney diseases, chronic obstructive pulmonary disease, substance use disorders, transplant procedures (bone marrow, solid organ), and nursing home stay status. AOR, adjusted odds ratio; CI, confidence interval
FIGURE 4
FIGURE 4
Six‐month hospitalization and mortality risks among three adult (age > 18) population: patients with both dementia (or Alzheimer's disease [AD]) and COVID‐19, patients with COVID‐19 but no dementia, and patients with dementia (or AD) but no COVID‐19. ***: P < .001; **: P < .01; ns, not significant
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. The Centers for Disease Control and Prevention (CDC). Cases in the U.S. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html (accessed on August 21, 2020).
    1. The Centers for Disease Control and Prevention (CDC) . Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID‐19. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidenc... (Accessed on August 21, 2020). - PubMed
    1. 2020 Alzheimer's disease facts and figures. Alzheimer's Dement. 2020; 16(3): 391‐460. - PubMed
    1. Nelis SM, Wu YT, Matthews FE, et al. The impact of co‐morbidity on the quality of life of people with dementia: findings from the IDEAL study. Age Ageing. 2019; 48(3): 361‐367. - PMC - PubMed
    1. Schubert CC, Boustani M, Callahan CM, et al. Comorbidity profile of dementia patients in primary care: are they sicker. J Am Geriatr Soc. 2006; 54(1): 104‐109. - PubMed

Publication types

MeSH terms